Seer Price to Book Ratio 2020-2022 | SEER

Historical price to book ratio values for Seer (SEER) over the last 10 years. The current price to book ratio for Seer as of July 01, 2022 is 1.26.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Seer Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2022-07-01 9.81 1.26
2022-03-31 15.24 $7.81 1.95
2021-12-31 22.81 $8.11 2.81
2021-09-30 34.53 $8.36 4.13
2021-06-30 32.78 $8.56 3.83
2021-03-31 50.02 $8.74 5.72
2020-12-31 56.14 $7.28 7.71
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.613B $0.007B
Seer Inc. is a life sciences company. It engages in developing Proteograph(TM), which is an integrated solution consisting of consumables, automation instrumentation and proprietary software. Seer Inc. is based in REDWOOD CITY, Calif.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $163.597B 9.95
Bio-Rad Laboratories (BIO.B) United States $14.907B 32.33
QIAGEN (QGEN) Netherlands $10.865B 17.15
Biohaven Pharmaceutical Holding (BHVN) United States $10.248B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.228B 0.00
Arcus Biosciences (RCUS) United States $1.901B 48.18
Emergent Biosolutions (EBS) United States $1.599B 6.85
Myovant Sciences (MYOV) United Kingdom $1.236B 0.00
Zymeworks (ZYME) Canada $0.320B 0.00
Gelesis Holdings (GLS) United States $0.114B 0.00
Enzo Biochem (ENZ) United States $0.104B 0.00
Ambrx Biopharma (AMAM) United States $0.103B 0.00
SQZ Biotechnologies (SQZ) United States $0.087B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00